HTT-lowering reverses Huntington's disease immune dysfunction caused by NF?B pathway dysregulation. (2014)

First Author: Träger U
Attributed to:  Targeting the innate immune system in Huntington's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/brain/awt355

PubMed Identifier: 24459107

Publication URI: http://europepmc.org/abstract/MED/24459107

Type: Journal Article/Review

Volume: 137

Parent Publication: Brain : a journal of neurology

Issue: Pt 3

ISSN: 0006-8950